Veru Inc (VERU) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $2.66
• Market Cap: $41.89M
• EPS: $-1.21
• 52-Week High: $7.40
• 52-Week Low: $2.10

Market Sentiment

Veru Inc currently has a Bullish sentiment score of 0.34.

About Veru Inc

Veru Inc. is a clinical-stage biopharmaceutical company headquartered in Miami, Florida, specializing in the development of innovative therapeutics for oncology and other unmet medical needs. The company's pipeline includes a range of drug candidates aimed at addressing various types of cancers, with a particular emphasis on both novel treatments and enhancements to existing therapies. Committed to advancing patient care, Veru leverages its proprietary technology and scientific expertise to b...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Veru Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VERU pay dividends?

Veru Inc (VERU) does not currently pay a regular dividend.

What is VERU's market cap?

Veru Inc (VERU) has a market capitalization of $41.89M with a current stock price of $2.66.